Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden have?
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden has 367 citations in the OpenAlex counts ScholarIQ stores.
When was Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden published?
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden has 2011 year in the ScholarIQ index.
What is the open-access status of Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden?
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden has closed oa status in the ScholarIQ index.
What is the DOI of Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden?
The DOI for Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden is on the source record.
What is the PMID of Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden?
The PMID for Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden is on the source record.
What is the OpenAlex record for Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden?
The OpenAlex for Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden is on the source record.